Literature DB >> 7136628

Trace metals in cystic fibrosis.

M van Caillie-Bertrand, F de Biéville, H Neijens, K Kerrebijn, J Fernandes, H Degenhart.   

Abstract

Serum zinc and copper concentration, 24 hrs urinary zinc and copper excretion, plasma selenium and red blood cell glutathione peroxidase activity were measured in 13 cystic fibrosis patients aged 6 to 15 years. The mean serum zinc value +/- S.D. (17.3 mumol/l +/- 4.6) did not differ from that of the control group (17.9 mumol/l +/- 3.1). Urinary zinc excretion in 12 out of 13 patients was within the normal range (1.53-13.8 mumol/24 hrs). The mean serum copper +/- S.D. (23.8 mumol/l +/- 4.2) was not significantly elevated as compared to the value found in the control group (19.2 mumol/l +/- 3.5), but 4 children, including 1 with documented portal hypertension, showed an urinary copper excretion greater than 0.94 mumol/24 hrs (normal: 0.16-0.80 mumol/24 hrs). Mean plasma selenium +/- S.D. (0.84 mumol/l +/- 0.25) was significantly reduced as compared to the control group (1.0 mumol/l +/- 0.15) (p less than 0.05). The correlation between selenium concentration and RBC glutathione peroxidase activity was significant (p less than 0.01). A negative correlation was also found between plasma selenium and 24 hrs faecal fat excretion (p less than 0.05). It is concluded that CF children with severe dysfunction of the exocrine pancreas are at increased risk to develop symptoms of subclinical or manifest zinc and/or selenium deficiency. Appropriate supplementation should therefore systematically be considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7136628     DOI: 10.1111/j.1651-2227.1982.tb09400.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  6 in total

1.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 3.  Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology.

Authors:  J A Dodge
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

4.  The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.

Authors:  J A Ziemniak; B M Assael; R Padoan; J J Schentag
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Plasma chromium concentrations in normal infants and cystic fibrosis patients.

Authors:  D Bougle; F Bureau; J Voirin; D Neuville; M Drosdowsky; J F Duhamel
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

6.  Erythrocyte and plasma trace element levels in clinical assessments : Zinc, copper, and selenium in normals and patients with Down's syndrome and cystic fibrosis.

Authors:  J Nève; L Molle; M Hanocq; P M Sinet; R Van Geffel
Journal:  Biol Trace Elem Res       Date:  1983-04       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.